itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Job Pivots in the Age of AI: Lessons From Mike Mulligan and His Steam Shovel

    3 апреля, 2026

    Matt Harrison Clough As organizations like Amazon, PwC, and Microsoft have announced AI-fueled layoffs, it’s no surprise that half of Americans have expressed concern about AI’s larger potential impact on their jobs. Of course, companies can attribute layoffs to AI efficiencies while trimming workforces for various reasons. Yet there is no question that artificial intelligence… →

    Management
  • The Founder of OpenCV Is Speaking at OSCCA, Don’t Miss It!

    3 апреля, 2026

    Over 1.5 billion downloads. Used in everything from self-driving cars to medical imaging to robotics. OpenCV has become the backbone of modern computer vision — and it all started with one person. Gary Bradski, the founder of OpenCV, is coming to OSCCA, the OpenCV-SID Conference on Computer Vision & AI, on May 4th in Los… →

    Computer Vision
    CV, OpenCV
  • Comparative analysis of postoperative pain following bioceramic sealer application with three obturation methods: A randomized controlled trial

    2 апреля, 2026

    CONCLUSIONS: The sealer-based and hot modified methods significantly reduced postoperative pain compared to traditional techniques. These findings support the clinical adoption of innovative bioceramic sealer techniques to optimize pain management and patient satisfaction. →

    Clinical Trials
  • Impact of Digital Remote Monitoring on the Optimization of Guideline-Directed Medical Therapy Titration in Heart Failure With Reduced Ejection Fraction

    2 апреля, 2026

    Aim To evaluate the impact of digital remote monitoring on the effectiveness of intensive dose titration for guideline-directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF) for the achievement of target doses and the reduction of decompensated heart failure rate and all-cause mortality.Materials and methods The study utilized vital sign… →

    Clinical Trials
  • Novel application for the JAK inhibitor baricitinib in the treatment of Vogt-Koyanagi-Harada disease: a prospective cohort study

    2 апреля, 2026

    CONCLUSION: This study demonstrates that baricitinib is a promising therapeutic option for both early- and late-stage VKH disease. It effectively controls choroidal inflammation, improves visual function, and allows for a substantial reduction in corticosteroid burden with a favorable safety profile. →

    Clinical Trials
  • Sex Differences in Statin Intolerance: Insights From the CLEAR Outcomes Trial

    2 апреля, 2026

    CONCLUSIONS: This is the only cardiovascular outcomes trial to date that exclusively enrolled patients with statin intolerance, and the largest contemporary study of lipid lowering therapy in females, a group historically underrepresented in clinical trials. Bempedoic acid was equally tolerated by both sexes and represents a viable alternative to statins to reduce cardiovascular risk. →

    Clinical Trials
  • Vonoprazan Versus Tegoprazan-Amoxicillin Dual Therapy for Treatment-Naïve Patients With Helicobacter pylori Infection: A Prospective, Multicenter, Open-Label, Randomized Controlled Study

    2 апреля, 2026

    CONCLUSION: Vonoprazan/amoxicillin dual therapy achieved satisfactory H. pylori eradication rates with a favorable safety profile in treatment-naïve patients. Tegoprazan/amoxicillin dual therapy was associated with fewer gastrointestinal adverse event incidences, while optimizing tegoprazan dosing frequency may be necessary to improve the eradication. →

    Clinical Trials
  • The effect of inhaled dry salt on pulmonary mucociliary clearance in obstructive lung disease: A randomised, placebo-controlled, crossover study

    2 апреля, 2026

    CONCLUSIONS: Inhalation of 40 mg dry NaCl was well tolerated without acute adverse effects in COPD patients. However, early termination left the study underpowered, increasing the risk of type II error. Non-significant findings should not be interpreted as evidence of no effect. Larger, adequately powered trials are needed to clarify the impact of dry NaCl… →

    Clinical Trials
  • Psychologically informed reminder messages for promoting BRCA1/2 carrier screening: evidence from a large-scale population-based study

    2 апреля, 2026

    Psychologically Informed Reminder Messages (PIRMs) may promote health-behavior change, but their impact on preventive genetic screening is unclear. Due to low adherence to a screening program, Clalit Health Services initiated an intervention to encourage BRCA1/2 carrier screening in July 2022. This observational study assesses the effectiveness of the intervention in encouraging screening and its spillover… →

    Clinical Trials
  • The Best Customers to Study When Scaling Into a New Market

    2 апреля, 2026

    Carolyn Geason-Beissel/MIT SMR | Getty Images For tech companies worldwide, expanding into a new market is both a rite of passage and a moment of truth. It represents the transition from early promise to meaningful scale — an opportunity to increase revenue, signal growth potential to investors, and unlock powerful sources of differentiation, such as… →

    Management
Предыдущая страница
1 … 6 7 8 9 10 … 939
Следующая страница